Search results
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 hours agoModerna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript May 2, 2024 Moderna, Inc. beats...
Analysts Are Updating Their Moderna, Inc. (NASDAQ:MRNA) Estimates After Its First-Quarter Results
Simply Wall St. via Yahoo Finance· 9 hours agoModerna, Inc. (NASDAQ:MRNA) just released its quarterly report and things are looking bullish....
Decoding Moderna Inc (MRNA): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 16 hours agoModerna Inc (NASDAQ:MRNA) faces a significant decrease in revenue and net income, reflecting a 91%...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 2 days agoModerna stock broke out for the first time in a year on Thursday after beating Wall Street's...
Moderna First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 1 day agoModerna (NASDAQ:MRNA) First Quarter 2024 Results Key Financial Results Revenue: US$167.0m (down 91%...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 2 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 2 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 5 days agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 1 day agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Moderna ends gene editing alliance with Metagenomi
BioPharma Dive via Yahoo Finance· 2 days agoMetagenomi said the companies’ decision to part ways followed a “strategic prioritization” undertaken by Moderna, which has made several investments in...
